Sherbrooke and Eastern
Type of Organization
Field of Activity
Dynex Capital Corporation is a Canadian venture capital firm which invests primarily in biotechnology.
The firms General Partners have produced 20% to 30% compounded returns in four funds for Canadian institutional investors over the past 30 years. The partners are best described as experienced, aggressive and entrepreneurial problem solvers and company builders.
We are strategically partnered with an impressive group of leading corporations.
Canadian biotechnology is globally competitive. Canadian companies and research organizations generate world class research. In Canada research costs 40% - 50% less than equivalent research done in the United States. We believe that the Canadian biotechnology sector is significantly under funded and undervalued by the capital markets.